Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2019

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity

The following table presents certain information related to the activity of our non-vested stock option grants:

	Number of Stock Options	Weighted Average Exercise Prices		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2018	107,888	$	20.94	—	$	—
Granted	99,181	16.25		—	—
Less: Forfeited	—	—		—	—
Less: Exercised	—	—		—	—
Outstanding as of September 30, 2019	207,069	$	18.69	9.25	$	—
Vested as of September 30, 2019	9,822	$	20.44	8.98	$	—
Exercisable as of September 30, 2019	9,822	$	20.44	8.98	$	—

Schedule of Nonvested Share Activity

The following table presents certain information related to the activity of our non-vested common stock grants:

	Number of Restricted Shares	Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2018	217,936	$	18.96
Granted (1)	133,421	16.26
Less: Forfeited	6,059	20.15
Less: Vested	131,613	19.22
Outstanding as of September 30, 2019	213,685	$	17.51

Share-based Payment Arrangement, Activity

The following table presents our total stock-based compensation expense:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2019		2018		2019		2018
Employee stock-based compensation expense
Pre-tax	$	536	$	248	$	1,482	$	736
Post-tax (1)	424		196		1,171		581
Director stock-based compensation expense
Pre-tax	178		379		810		940
Post-tax (1)	141		299		640		743

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following weighted-average assumptions were used to value the stock options granted:

	2019
Expected annual dividend yield	1.28	%
Expected volatility	41.07	%
Risk-free interest rate	3.11	%
Expected term	6	years